Select Biosciences Ltd

News Headlines

Telik's TRAP Drug Discovery Technology Surpasses 3 Million Molecular Fingerprint Milestone
24 July 2008
The expanded library significantly enhances Telik's patented drug discovery technology, Target Related Affinity Profiling.

MorphoSys Licenses RapMAT Technology to Astellas
23 July 2008
Astellas has exercised a pre-existing option to use MorphoSys's RapMAT technology for antibody optimization as part of the existing technology transfer agreements.

Thermo Fisher Scientific Supplies Veeda Clinical Research with Watson LIMS
17 July 2008
Veeda Clinical Research selects Thermo Scientific Watson LIMS™ to automate its laboratory processes in its Bioanalytical Research facilities in India and UK.

OLIGOMERIX Funded by the Alzheimer's Drug Discovery Foundation to Evaluate Compounds Active against Tau Oligomers
08 July 2008
OLIGOMERIX will select compounds using its Alzheimer’s disease screening assays and will evaluate these compounds in a tauopathy mouse model.

ARTEL and IonGate Join Forces to Advance Drug Discovery Research in North America
25 June 2008
IonGate will leverage ARTEL’s expertise to increase the exposure and use of its discovery systems and assay development services in North America.

Trubion Pharmaceuticals Announces Extension of Research Period under its Wyeth Collaboration
20 June 2008
Wyeth's obligations to Trubion include collaboration research funding commitments of $3.2 million in exchange for research services through Dec. 22, 2009.

Metabolon Awarded Additional Metabolomics Patent
12 June 2008
The newly issued patent further expands the domain of previously issued patents to include multiple disease states related to nervous systems disorders.

Nuevolution Announces Drug Discovery Alliance with Lexicon Pharmaceuticals
12 June 2008
Nuevolution's Chemetics® drug discovery technology will be applied to identify small molecule lead compounds against Lexicon drug targets.

  
Select Conferences


Select Conferences